Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2971)	6/29/2010 12:08:02 PM
From: Jibacoa	1 Recommendation Read Replies (2) \| Respond to of 3722

PBTH is among the biotechs staying on the green today.<g> The stock is up about 2% on volume about 1/3 its ADV bigcharts.marketwatch.com PBTH announced that it has received formal Good Manufacturing Practice certification for hGH-CTP, its version of human growth hormone. GMP certification is required by the European Union clinical trials legislation as a precondition for conducting clinical trials in EU member countries. This certification allows PBTH to move forward with the PII of hGH-CTP, which they expect to start this Summer. As mentioned, the ACTAY is $8 I like the CTP technology and think that PBTH has good potential.<g> Will continue to watch closely and add to my present position when the time seems to be appropriate.<g> bigcharts.marketwatch.com Bernard